Potential Long-Term Benefit of Home Systolic Blood Pressure Below 125 mm Hg for Cardiovascular Risk Reduction: The J-HOP Study Extended

医学 血压 冲程(发动机) 心力衰竭 心脏病学 内科学 危险系数 冠状动脉疾病 糖尿病 风险因素 早晨 置信区间 内分泌学 机械工程 工程类
作者
Kazuomi Kario,Yukie Okawara,Hiroshi Kanegae,Satoshi Hoshide
出处
期刊:Hypertension [Ovid Technologies (Wolters Kluwer)]
标识
DOI:10.1161/hypertensionaha.123.22122
摘要

BACKGROUND: The long-term benefit of achieving the Japanese Society of Hypertension home systolic blood pressure (SBP) target of <125 mm Hg has not been fully evaluated. This study investigated the long-term risk of cardiovascular disease events in individuals with home SBP <125 versus 125 to <135 or ≥135 mm Hg who participated in the J-HOP study (Japan Morning Surge-Home Blood Pressure). METHODS: The J-HOP study enrolled outpatients with ≥1 cardiovascular risk factor between 2005 and 2012, with follow-up until March 2015 and extended follow-up from December 2017 to May 2018. Cardiovascular disease events (stroke, coronary artery disease, congestive heart failure, and aortic dissection) were compared between home SBP subgroups. RESULTS: During mean 5.9 years of follow-up in 4231 participants (mean age, 65 years), cardiovascular events included stroke (n=89), coronary artery disease (n=116), congestive heart failure (n=37), and aortic dissection (n=8). The adjusted 10-year risk of total cardiovascular disease was slightly higher, and stroke risk was significantly higher when baseline home SBP was ≥135 versus <125 mm Hg (adjusted hazard ratio, 1.39 [95% CI, 0.97–2.00] for overall cardiovascular disease and 2.68 [95% CI, 1.34–5.38] for stroke; this was largely due to between-group differences in the first 5 years of follow-up, which were maintained over the subsequent 5 years). Findings were similar in the subgroup of high-risk patients (those with diabetes or stroke history). CONCLUSIONS: These data highlight the potential long-term benefit of strict home SBP control and validate this as an appropriate Japanese Society of Hypertension guideline target although confirmation in larger populations is needed. REGISTRATION: URL: XXX; University Hospital Medical Information Network Clinical Trials Registry; Unique identifier: UMIN000000894 (Japan Morning Surge-Home Blood Pressure study).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男应助潘尼采纳,获得10
1秒前
zxh关闭了zxh文献求助
1秒前
1秒前
角落完成签到 ,获得积分10
2秒前
邵辛关注了科研通微信公众号
2秒前
3秒前
3秒前
魔幻友菱发布了新的文献求助10
3秒前
WSDSG发布了新的文献求助10
3秒前
Dr.c发布了新的文献求助10
4秒前
4秒前
科研通AI2S应助fei采纳,获得10
5秒前
小超发布了新的文献求助10
5秒前
5秒前
5秒前
5秒前
lkb发布了新的文献求助10
6秒前
科研菜坤发布了新的文献求助10
6秒前
高兴曼寒完成签到,获得积分10
7秒前
7秒前
Able阿拉基发布了新的文献求助10
7秒前
8秒前
王富贵儿发布了新的文献求助10
8秒前
tamaco发布了新的文献求助10
9秒前
XY完成签到,获得积分10
9秒前
splatoon完成签到,获得积分10
9秒前
英姑应助Jun采纳,获得10
9秒前
10秒前
11秒前
春夏秋冬发布了新的文献求助10
11秒前
科研通AI2S应助刘维尼采纳,获得10
11秒前
云淡风清发布了新的文献求助10
11秒前
无花果应助Dr.c采纳,获得10
12秒前
科研通AI2S应助SC采纳,获得10
12秒前
lkb完成签到,获得积分10
12秒前
erhgbw应助ahjbdadjk采纳,获得10
12秒前
13秒前
yff发布了新的文献求助10
14秒前
Zpiao发布了新的文献求助10
14秒前
15秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3144274
求助须知:如何正确求助?哪些是违规求助? 2795879
关于积分的说明 7816861
捐赠科研通 2451946
什么是DOI,文献DOI怎么找? 1304774
科研通“疑难数据库(出版商)”最低求助积分说明 627291
版权声明 601419